Targeting Aberrant TGF-&bgr; Signaling in Pre-Clinical Models of Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 7, Iss. 5, 2007-01 ,pp. : 504-514

Bentham Science Publishers

Access to resources Recommend Favorite

The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models

By Lukacova Slavka   Søørensen Brita S.   Alsner Jan   Overgaard Jens   Horsman Michael R.  

Acta Oncologica, Vol. 47, Iss. 5, 2008-06 ,pp. : 941-947

Informa Healthcare

Access to resources Recommend Favorite

Pre-clinical development of farnesyltransferase inhibitors

By Lobell R.B.   Kohl N.E.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 2, 1998-06 ,pp. : 203-210

Springer Publishing Company

Access to resources Recommend Favorite

Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models

By                

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 2047-2053

Spandidos Publications

Access to resources Recommend Favorite

Expression of sex steroid receptor genes and comodulation with retinoid signaling in normal human uroepithelial cells and bladder cancer cell lines - Epidemiologic, pre-clinical and clinical observations

By Waliszewski P.   Waliszewska M.K.   Hemstreet G.P.   Hurst R.E.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 5, 1997-09 ,pp. : 141-147

Elsevier

Access to resources Recommend Favorite